4527 — Rohto Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapFalling Star

Annual balance sheet for Rohto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	R2020 March 31st	R2021 March 31st	C2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	45,307	52,964	72,791	79,951	89,210
Net Total Accounts Receivable
Net Total Receivables	50,416	47,865	51,682	60,656	69,115
Total Inventory
Total Other Current Assets
Total Current Assets	130,706	133,071	164,306	190,246	214,759
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	48,539	49,790	62,839	66,182	68,607
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	215,644	226,149	274,876	309,677	346,175
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	62,117	56,471	71,488	80,162	87,087
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	76,361	70,241	96,476	100,107	99,849
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	139,283	155,908	178,400	209,570	246,326
Total Liabilities & Shareholders' Equity	215,644	226,149	274,876	309,677	346,175
Total Common Shares Outstanding